Abstract
A candidate reference measurement procedure (RMP) for serum theophylline via isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. With a single-step precipitation pretreatment and a 6-min gradient elution, the method achieved baseline separation of theophylline and its analogs on a C18-packed column. A bracketing calibration method was used to ensure repeatable signal intensity and high measurement precision. The intra-assay and inter-assay imprecisions were 1.06%, 0.84%, 0.72% and 0.47%, 0.41%, 0.25% at concentrations of 4.22 µg/mL (23.40 µmol/L), 8.45 µg/mL (46.90 µmol/L), and 15.21 µg/mL (84.43 µmol/L), respectively. Recoveries ranged from 99.35 to 102.34%. The limit of detection (LoD) was 2 ng/mL, and the lowest limit of quantification (LLoQ) was 5 ng/mL. The linearity range extended from 0.47 to 60 µg/mL (2.61–333.04 µmol/L). No ion suppression and carry-over (< 0.68%) were observed. The relative bias for this candidate RMP that participated in 2023 External Quality Control for Reference Laboratories (RELA) conducted by the International Federation of Clinical Chemistry (IFCC) was within a range of 0.17 to 0.93%. Furthermore, two clinical immunoassay systems were compared with this candidate RMP, demonstrating good correlations. The results of the Trueness Verification Plan indicate significant differences among routine systems, highlighting the need for standardization efforts. The developed candidate RMP for serum theophylline serves as a precise reference baseline for standardizing clinical systems and assigning values to reference materials.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-024-05415-5/MediaObjects/216_2024_5415_Fig6_HTML.png)
References
Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2013;188(8):901–6.
Reyes-García J, Díaz-Hernández V, Carbajal-García A, Casas-Hernández MF, Sommer B, Montaño LM. Theophylline-induced relaxation is enhanced after testosterone treatment via increased KV1.2 and KV1.5 protein expression in guinea pig tracheal smooth muscle. Int J Mol Sci. 2023;24(6):5884.
Barnes PJ. Theophylline. Pharmaceuticals (Basel). 2010;3(3):725–47.
Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med. 2003;167(6):813–8.
Pflieger T, Venkatesh R, Dachtler M, Cooke K, Laufer S, Lunter D. Influence of design parameters on sustained drug release properties of 3D-printed theophylline tablets. Int J Pharm. 2024;658:124207.
Babu AR, Thippeswamy B, Vinod AB, Ramakishore EG, Anand S, Senthil D. Determination of theophylline in rabbit plasma by triple quadrupole LC/MS. Pharm Methods. 2011;2(4):211–7.
Al-Jenoobi FI, Ahad A, Raish M, Al-Mohizea AM, Alam MA. Investigating the potential effect of Commiphora myrrha on the pharmacokinetics of theophylline, a narrow therapeutic index drug. Drug Res (Stuttg). 2015;65(6):312–6.
Mitenko PA, Ogilvie RI. Rational intravenous doses of theophylline. N Engl J Med. 1973;289(12):600–3.
Tachi T, Hase T, Okamoto Y, Kaji N, Arima T, Matsumoto H, et al. A clinical trial for therapeutic drug monitoring using microchip-based fluorescence polarization immunoassay. Anal Bioanal Chem. 2011;401(7):2301–5.
Nishiyama K, Sugiura K, Kaji N, Tokeshi M, Baba Y. Development of a microdevice for facile analysis of theophylline in whole blood by a cloned enzyme donor immunoassay. Lab Chip. 2019;19(2):233–40.
Sarkar MA, Hunt C, Guzelian PS, Karnes HT. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos. 1992;20(1):31–7.
ISO 15193. In vitro diagnostic medical devices – measurement of quantities in samples of biological origin – requirements for content and presentation of reference measurement procedures. Geneva: International Organization for Standardization; 2009.
ISO 15194. In vitro diagnostic medical devices – measurement of quantities in samples of biological origin – requirements for certified reference materials and the content of supporting documentation. Geneva: International Organization for Standardization; 2009.
ISO 15195. Laboratory medicine – requirements for the competence of calibration laboratories using reference measurement procedures. Geneva: International Organization for Standardization; 2018.
Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem. 2009;42(4–5):236–40.
Joint Committee for Traceability of Laboratory Medicine. Database of higher order reference materials; measurement methods/procedures and services. http://www.bipm.org/jctlm/. Accessed Jan 2024.
Désage M, Soubeyrand J, Soun A, Brazier JL, Georges Y. Automated theophylline assay using gas chromatography and a mass-selective detector. J Chromatogr. 1984;336(2):285–91.
Thienpont LM, Van Nieuwenhove B, Stöckl D, De Leenheer AP. Candidate reference method for determining serum theophylline applied to target-setting in external quality assessment and routine method evaluation. Clin Chem. 1994;40(8):1503–11.
Kress M, Meissner D, Kaiser P, Hanke R, Wood WG. The measurement of theophylline in human serum or plasma using gas chromatography and isotope dilution-mass spectrometry (GC-IDMS) taking other substituted xanthines into consideration. Clin Lab. 2002;48(9–10):535–40.
Zhang Y, Mehrotra N, Budha NR, Christensen ML, Meibohm B. A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens. Clin Chim Acta. 2008;398(1–2):105–12.
Chae JW, Kim DH, Lee BY, Kim EJ, Kwon KI. Development and validation of a sensitive LC-MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;889–890:44–9.
Han L, Huang X, Zhang L, Zhang Q, Wang J, Lin H, et al. Candidate reference measurement procedure for determination of urea in serum by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2019;162:124–9.
Huang X, Zhang Q, Zheng S, Wang J, Han L, Lin H, et al. Measurement of human serum unconjugated estriol without derivatization using liquid chromatography-tandem mass spectrometry candidate reference method and compared with two immunoassays. Anal Bioanal Chem. 2018;410(24):6257–67.
Mineva EM, Schleicher RL, Chaudhary-Webb M, Maw KL, Botelho JC, Vesper HW, et al. A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D₃ and 25-hydroxyvitamin D₂ using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2015;407(19):5615–24.
Yan J, Lin H, Xu Y, Yu L, Chen S, Zhang Q, et al. Measurement of serum uric acid by isotope dilution liquid chromatography tandem mass spectrometry: modification of a candidate reference measurement method and its clinical application. Int J Mass Spectrom. 2022;482:116911.
CLSI. Evaluation of precision of quantitative measurement procedures; Approved guideline – third edition. CLSI document EP5-A3. Wayne: Clinical and Laboratory Standards Institute; 2014.
CLSI. User verification of performance for precision and trueness; Approved guideline – second edition. CLSI document EP15-A2. Wayne: Clinical and Laboratory Standards Institute; 2006.
CLSI. Evaluation of linearity of quantitative measurement procedures – a statistical approach; Approved guideline. CLSI document EP6-A. Wayne: Clinical and Laboratory Standards Institute; 2006.
CLSI. Interference testing in clinical chemistry; Approved guideline – second edition. CLSI document EP7-A2. Wayne: Clinical and Laboratory Standards Institute; 2005.
CLSI. Evaluation of matrix effects; Approved guideline – second edition. CLSI document EP14-A2. Wayne: Clinical and Laboratory Standards Institute; 2005.
CLSI. Liquid chromatography-mass spectrometry methods; Approved guideline. CLSI document C62-A. William C: Clinical and Laboratory Standards Institute; 2014.
ISO/IEC. Guide 98–3:2008. Uncertainty of measurement – Part 3: Guide to the expression of uncertainty in measurement. Geneva: International Organization for Standardization; 2008.
Westgard JO. Managing quality vs. measuring uncertainty in the medical laboratory. Clin Chem Lab Med. 2010;48(1):31-40.
CLSI. Measurement procedure comparison and bias estimation using patient samples; Approved guideline – third edition. CLSI document EP09-A3. Wayne: Clinical and Laboratory Standards Institute; 2013.
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). RELA-IFCC external quality assessment scheme for reference laboratories in laboratory medicine. http://dgkl-rfb.de:81/. Accessed Jan 2024.
ISO Guide 35. Technical Committee ISO/TC 334 Reference materials, 2017. ISO Guide 35:2017 Reference Materials – Guidance for Characterization and Assessment of Homogeneity and Stability, 2022.
Acknowledgements
We sincerely appreciate Reference System Center of Maccura Biotechnology Co., Ltd. for value assignment for trueness verification samples. We also appreciate the organization by Guangdong Center of Clinical Laboratory and Chongqing Center of Clinical Laboratory for the Trueness Verification Plan in Southern China.
Funding
This work was supported by the Guangdong Basic and Applied Basic Research Foundation (grant numbers 2021A1515220149 and 2021A1515220114); the Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine (grant number BJ2022KY04); and The Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine (grant numbers YN2022QN16 and YN2019QL03).
Author information
Authors and Affiliations
Contributions
Yuanyuan Du: investigation; methodology; data curation; visualization; validation; writing—original draft. Qiaofang Yan: investigation; methodology; data curation; visualization; writing—original draft and editing. Min Zhan, Qiaoxuan Zhang, and Di Huang: investigation; validation; writing—review and editing. Pengwei Zhang and Jun Yan: methodology; data curation, software. Jianbing Wang: validation, supervision writing—review and editing. **anzhang Huang and Liqiao Han: conceptualization; funding acquisition; methodology; supervision; validation; writing—review and editing.
Corresponding authors
Ethics declarations
Ethics approval
The collection of leftover serum samples was approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (ZE2019-149-01).
Informed consent
The ethics committee approved the exemption of informed consent.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Du, Y., Yan, Q., Zhan, M. et al. Evaluation and clinical application of a bracketing calibration-based isotope dilution liquid chromatography-tandem mass spectrometry candidate reference measurement procedure for serum theophylline. Anal Bioanal Chem (2024). https://doi.org/10.1007/s00216-024-05415-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00216-024-05415-5